Le myélome multiple: Un nouveau cancer induit par un virus ?

Medecine/Sciences

Volumn 14, Issue 6-7, 1998, Pages 736-741

  Tarte, Karin ^a   Klein, Bernard ^b  

^a INSERM   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26844511942     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1129     Document Type: Article

References (38)

1. Kyle RA. «Benign» monoclonal eammopathy - after 20 to 35 years of follow up. Mayo Clin Proc 1993; 68: 26-36.
2. Hallek M, Bergsagel PL, Andcrson KG. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91: 3-21.
3. Klein B, Bataille R. Interleukine-6 et myélome multiple chez l'homme. Med Sci 1991 ; 7:937-43.
4. Chang Y, Cesarman E, Pcssin MS, Lee F, Culpepper j, Knowles DN1, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
5. Moore PS, BoshoffC, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739-44.
6. Melden I, Chang Y, You Y, Moore PS, Goldsmith SlA. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL- 6) activates signaling through the shared gplSO receptor subunit. J Biol Chem 1997;272: 19620-31.
7. Gramatzki M, Burger R, Neipel F, Fleckenstein B. Human herpesvirus type 8 (HHV-8) interleukin-6 homologue is functionally active on human myeloma cells. B/oorfl997;90:87a.
8. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
9. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-80.
10. Parravinci C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seroneeative Castleman's disease. Am J Pathol 1997; 151: 1517-22.
11. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997; 276: 1851-4.
12. Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nat Med 1997; 3: 293-8.
13. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden-Kent, Paterson H, Weiss RA, Mittnacht S. Cyclin encoded by KS herpesvirus. Nature 1996; 382 : 410.
14. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo J[, Moore PS, Chang Y, Knowles DM. ; Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996; 70: 8218-23.
15. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the Interferon signaling pathway. Oncogene 1997; 15: 1979-85.
16. Said JW, Rettig MR, Heppner K, Vescio RA, Schiller G, et al. Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 1997; 90: 4278-82.
17. Brousset P, Meggetto F, Attal M, Delsol G. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997; 278: 1972.
18. Vescio RA, Ma HJ, Moss T, Schiller G, Said JW, Berenson J. Detection of Kaposi's sarcoma-associated herpesvirus in the dendritic cells of Waldenstrom's macroglobulinemia and primary amyloidosis patients. Blood 1997;90:86a.
19. Vescio RA, Moss T, Ma HJ, Schiller G, Berenson J. Detection of Kaposi's sarcomaassociated herpesvirus in me peripheral blood of multiple myeloma patients. Blood 1997;90:587a.
20. Vescio RA, Wu C, Rettig MR, Stewart AK, Ballester OF, et al. The detection of KSHV is increased by mobilization chemotherapy and reduced in autografts by CD34-selecuon. Blood 1997; 90: 565a.
21. Parravicini C, Lauri E, Baldini L, Neri A, Poli F, Sirchia G, Moroni M, Galli M, Corbellino M. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 1997; 278: 1969-70.
22. + cells in multiple myeloma patients. Blood 1997; 90: 86a.
23. Tarte K, Olsen SI, Lu ZY, Legouffe E, Rossi JF, Chang Y, Klein B. Clinical grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi's sarcoma-associated herpesvirus. Blood 1998;91: 1852-7.
24. Gao SI, Kingsley L, Li M, Zheng W, Parravicini C, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2 : 925-8.
25. Geddes M, Franceschi S, Barchielli A, Falcini F, Carli S, Cocconi G, Conti E, Crosignani P, Gafa L, Giarelli L. Kaposi's sarcoma in Italy before and after the AIDS epidemic. RrJ Cancer 1994 ; 69: 333-6.
26. Riedel DA, Pottern LM. The epidemiology of multiple myeloma. Hematol Oncol CKn North Am 1992; 6: 225-47.
27. Masala G, Di Lollo S, Picoco C, Crosignani P, Demicheli V, et al. Incidence rates of leukemias, lymphomas and myelomas in Italy: geographic distribution and NHL histotypes. IntJ Cancer WM; 68: 156-9.
28. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent iminunofluorescence antigen. Lancet 1996; 348: 1133-8.
29. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858-61.
30. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233-41.
31. Tarte K, Lu ZY, Fiol G, Legouffe E, Rossi JF, Klein B. Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma. Blood 1997; 90: 3482-95.
32. Davis DA, Humphrey RW, Newcomb FM, O'Brien TR, Goedert JJ, Straus SE, Yarchoan R. Detection of senim antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis 1997; 175: 1071-9.
33. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Sturzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 1997; 71: 7963-8.
34. Masood R, Zheng T, Tulpule A, Arora N, Chatl)-nne L, Handy M, Whitman J. Kaposi's sarcoma-associated nerpesvirus and multiple myeloma. Science 1997; 278: 1970-1.
35. Marcelin AG, Dupin N, Bouscary D, Bossi P, Cacoub P, Ravaud P, Calvez V. HHV-8 and multiple myeloma in France. Lfln1997;350: 1144.
36. Mackenzie J, Sheldon J, Cook G, Schulz TF, Tarret RF. HHV-8 and multiple myeloma in the UK. Lancet 1997; 350: 1144-5.
37. Parravicini C, Lauri E, Baldini L, Neri A, Poli F, Sirchia G, Moroni M, Galli M, Corbellino M. Kaposi's sarcoma-associated herpesvirus and multiple myeloma. Science 1997; 278: 1969.
38. Whitby D, Boshoff C, Luppi M, Torelli G. Kaposi s sarcoma-associated herpesvirus and multiple myeloma. Science 1997; 278: 1971-2.